Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Boehringer-Ingelheim
Company Monitoring Page for Boehringer-Ingelheim
latest headlines for company on cafepharma
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Tags:
Boehringer Ingelheim
,
Cyltezo
,
biosimilars
,
Humira
,
drug pricing
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Mon, 10/2/23 - 06:34 pm
Tags:
Boehringer Ingelheim
,
biosimilars
,
AbbVie
,
Humira
,
unbranded biosimilars
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Medicare
,
Jardiance
,
FDA
,
chronic kidney disease
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare
,
HHS
,
Pfizer
,
Bristol Myers Squibb
,
Eli Lilly
,
Boehringer Ingelheim
,
AstraZeneca
,
AbbVie
,
Novo Nordisk
,
JNJ
,
drug pricing
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
BioSpace
Tue, 08/22/23 - 09:49 am
Tags:
Boehringer Ingelheim
,
drug pricing
,
legal
,
Medicare
,
Inflation Reduction Act
Boehringer preps phase 3 for dual-action obesity drug
Pharmaphorum
Thu, 08/17/23 - 09:54 am
Tags:
Boehringer Ingelheim
,
clinical trials
,
obesity
,
survodutide
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
Tags:
CMS
,
Medicare
,
drug pricing
,
Bristol Myers Squibb
,
Janssen
,
Merck
,
Pfizer
,
Amgen
,
Boehringer Ingelheim
,
Pharmacyclics
,
AstraZeneca
,
Astellas
,
GSK
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
Tags:
NASH
,
Boehringer Ingelheim
,
Zealand Pharma
,
Akero Therapeutics
,
Axcella Health
,
Eli Lilly
,
Pfizer
,
Ionis Pharmaceuticals
,
Cascade
,
AstraZeneca
,
Gilead Sciences
,
Novo Nordisk
,
Ascletis Pharma
,
MediciNova
Boehringer Ingelheim posts more Jardiance growth as potential US kidney disease approval nears
Fierce Pharma
Tue, 08/1/23 - 10:35 pm
Tags:
Boehringer Ingelheim
,
Jardiance
,
diabetes
,
earnings
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars
,
Humira
,
AbbVie
,
rebates
,
drug pricing
,
Amgen
,
Celltrion
,
Novartis
,
Boehringer Ingelheim
,
Biocon
,
Fresenius
,
Sandoz
,
Organon
,
Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
Tags:
AbbVie
,
Skyrizi
,
Amgen
,
Otezla
,
Boehringer Ingelheim
,
psoriasis
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Tags:
Boehringer Ingelheim
,
Eli Lilly
,
Jardiance
,
Europe
,
chronic kidney disease
,
Forxiga
Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare
Fierce Pharma
Thu, 07/20/23 - 09:42 pm
Tags:
Novo Nordisk
,
Eli Lilly
,
Boehringer Ingelheim
,
obesity
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie
,
Humira
,
biosimilars
,
Boehringer Ingelheim
,
Organon
,
Samsung Bioepsis
,
Sandoz
,
Fresenius Kabi
,
Celltrion
,
Coherus Biosciences
,
Biocon
Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect
Fierce Biotech
Sun, 06/25/23 - 09:46 pm
Tags:
Boehringer Ingelheim
,
obesity
,
clinical trials
,
Zealand Pharma
,
survodutide
Sanofi says arbitration court rejects Boehringer's Zantac claims
Reuters
Wed, 06/21/23 - 10:53 am
Tags:
Sanofi
,
Boehringer Ingelheim
,
Zantac
,
legal
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
Synjardy
,
type 2 diabetes
,
pediatric
,
FDA
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
Tags:
IPF
,
Roche
,
Esbriet
,
Pirespa
,
Boehringer Ingelheim
,
Ofev
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wed, 05/31/23 - 06:59 pm
Tags:
Yuhan
,
cancer
,
Boehringer Ingelheim
,
Takeda
,
HER2 inhbitor
,
non-small cell lung cancer
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
BioSpace
Wed, 05/10/23 - 10:21 am
Tags:
Boehringer Ingelheim
,
Zealand Pharma
,
obesity
,
clinical trials
,
BI 456906
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.